Purdue's Bid To Split OxyContin Patent Suit Gets Rejected
A New Jersey federal judge on Tuesday declined to split into two phases any such trial in Depomed Inc.'s suit alleging Purdue Pharma LP's pain reliever OxyContin infringed on three of...To view the full article, register now.
Already a subscriber? Click here to view full article